Latvian pharmaceutical company Olpha has celebrated the topping-out of its new finished dosage form manufacturing facility, marking a major milestone in the company’s expansion. A commemorative time capsule was also embedded in the foundations of the new building. Olpha is investing EUR 5.84 million in the project, which will significantly increase its manufacturing capacity, support the production of new medicines and further modernise its operations.